Xenical vs Saxenda UK | Compare Weight Loss Treatments
Xenical vs Saxenda: Next Day Delivery UK Available
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Orlos (Orlistat) 60mg Weight Loss Aid - 84 Capsules
Xenical vs Saxenda: Which Weight Loss Treatment Works Best?
Published on: June 03, 2026
Choosing between xenical vs saxenda uk pharmacy options requires understanding how these two MHRA-licensed treatments work differently. Xenical (orlistat) blocks dietary fat absorption through tablets taken with meals, whilst Saxenda (liraglutide) is a daily injectable GLP-1 receptor agonist that regulates appetite and blood sugar. At Cured Pharmacy, both treatments are available from £32.00 with free UK prescriber consultation and discreet next day delivery across the UK.
How Xenical Works: Fat Blocker Mechanism
Xenical contains orlistat 120mg, a lipase inhibitor that prevents approximately 30% of dietary fat from being absorbed in your digestive system [1]. Unlike appetite suppressants, orlistat works locally in the gut without entering your bloodstream, making it suitable for patients who prefer non-systemic treatments.
Clinical trials demonstrate that patients taking orlistat alongside a reduced-calorie diet achieved an average 10% body weight reduction over 12 months, compared to 6% with diet alone [1]. The medication must be taken with each main meal containing fat, up to three times daily, and works only when dietary fat is present.
Because orlistat blocks fat absorption rather than suppressing appetite, you'll need to follow a lower-fat diet to minimise gastrointestinal side effects. This mechanism makes Xenical particularly effective for patients whose weight gain relates primarily to high-fat food consumption rather than portion control or frequent snacking.
How Saxenda Works: GLP-1 Appetite Regulation
Saxenda contains liraglutide 3mg, a glucagon-like peptide-1 (GLP-1) receptor agonist administered via daily subcutaneous injection [2]. Unlike Xenical's local gut action, Saxenda works systemically by mimicking a natural hormone that regulates appetite, slows gastric emptying, and improves blood sugar control.
The SCALE Obesity and Prediabetes trial showed that patients using Saxenda achieved an average 8% body weight reduction over 56 weeks, with 63.2% of participants losing at least 5% of their initial body weight [2]. Liraglutide activates GLP-1 receptors in the brain's appetite centres, creating genuine feelings of fullness rather than simply blocking nutrient absorption.
Saxenda requires daily injections using a pre-filled pen, with doses gradually increased over five weeks from 0.6mg to the maintenance dose of 3mg. This titration schedule helps minimise common side effects like nausea whilst allowing your body to adapt to the medication's appetite-suppressing effects.
Who Benefits Most from Injectable GLP-1 Treatments?
Saxenda suits patients who struggle with portion control, frequent snacking, or appetite regulation rather than specific dietary fat intake. The systemic appetite suppression can be particularly effective for emotional eating patterns or those who find traditional calorie restriction difficult to maintain long-term.
Xenical vs Saxenda: Key Differences Explained
The fundamental difference lies in mechanism: Xenical prevents fat absorption locally in your gut, whilst Saxenda regulates appetite through your endocrine system. This means Xenical requires dietary compliance to avoid gastrointestinal side effects, whereas Saxenda demands daily injections but offers systemic appetite control.
Xenical tablets are taken orally with meals, making administration simpler for patients uncomfortable with self-injection. However, the fat-blocking mechanism means you must limit dietary fat to 30% of daily calories to minimise oily stools, flatulence, and faecal urgency — side effects that resolve when fat intake is controlled [1].
Saxenda's injectable format requires more commitment but provides consistent appetite suppression throughout the day. Common side effects include nausea, diarrhoea, and constipation, particularly during dose escalation, though these typically improve after several weeks [2]. Your UK prescriber will assess your medical history, weight loss goals, and lifestyle factors to determine which treatment aligns with your needs.
Treatment Duration and Long-Term Use
Both treatments are intended for long-term use alongside lifestyle modifications. Xenical can be used continuously for up to two years, whilst Saxenda is typically prescribed for ongoing use provided you achieve at least 5% weight loss within the first 12 weeks. Neither medication should be considered a short-term solution — sustainable weight management requires continued treatment and behavioural changes.
| Feature | Xenical (Orlistat) | Saxenda (Liraglutide) |
|---|---|---|
| Mechanism | Blocks 30% dietary fat absorption | GLP-1 receptor agonist suppresses appetite |
| Administration | Oral capsule with meals | Daily subcutaneous injection |
| Dosing frequency | Up to 3 times daily with meals | Once daily injection |
| Average weight loss | 10% over 12 months (with diet) | 8% over 56 weeks (with diet) |
| Common side effects | Oily stools, flatulence, faecal urgency | Nausea, diarrhoea, constipation |
| Dietary requirements | Low-fat diet essential (≤30% calories from fat) | Reduced-calorie diet recommended |
| Starting price at Cured Pharmacy | From £32.00 (generic orlistat) | Prescription assessment required |
Xenical vs Saxenda Efficacy: Clinical Trial Data
Head-to-head comparisons are limited, but individual trial data provides clear efficacy benchmarks. The XENDOS study followed 3,305 patients on orlistat for four years, demonstrating sustained weight loss averaging 5.8kg compared to 3.0kg with placebo, alongside a 37% reduction in type 2 diabetes incidence [3].
Saxenda's SCALE trials showed greater average weight loss — 8% body weight reduction over 56 weeks compared to 2.6% with placebo [2]. However, direct comparison is complicated by different trial designs, patient populations, and dietary interventions. Both medications significantly outperform placebo when combined with reduced-calorie diets and increased physical activity.
Your individual response depends on adherence, baseline BMI, metabolic factors, and dietary patterns. Patients who maintain structured meal timing and consistent fat intake often achieve excellent results with Xenical, whilst those requiring stronger appetite suppression may respond better to Saxenda's GLP-1 mechanism. Your UK prescriber will review your weight loss history and eating behaviours during consultation.
Side Effects: What to Expect from Each Treatment
Xenical's side effects are predominantly gastrointestinal and directly related to dietary fat intake. Oily spotting, flatulence with discharge, faecal urgency, and fatty or oily stools occur in 15-30% of patients but can be minimised by limiting fat to 15g per meal [1]. These effects serve as behavioural reinforcement — high-fat meals produce immediate consequences that encourage dietary compliance.
Saxenda's most common side effects include nausea (39% of patients), diarrhoea (21%), constipation (20%), and vomiting (16%) during the dose escalation phase [2]. These gastrointestinal effects typically diminish after 4-8 weeks as your body adapts. Rare but serious risks include pancreatitis, gallbladder disease, and potential thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain.
Both treatments require monitoring. Xenical may reduce absorption of fat-soluble vitamins (A, D, E, K), so your prescriber may recommend a multivitamin supplement taken at least two hours before or after orlistat. Saxenda requires caution in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Managing Side Effects Effectively
For Xenical users, keeping a food diary helps identify fat triggers and optimise meal composition. For Saxenda patients, taking the injection at consistent times, staying well-hydrated, and eating smaller, more frequent meals can significantly reduce nausea. Your pharmacist can provide practical strategies tailored to your specific side effect profile.
Cost, Availability and Next Day Delivery at Cured Pharmacy
At Cured Pharmacy, Xenical orlistat 120mg capsules start from £32.00, whilst generic orlistat is available from £32.00 for patients seeking cost-effective fat-blocking treatment. Both contain identical active ingredients — the price difference reflects brand licensing rather than efficacy. All orlistat products require online consultation with our UK prescribers before dispensing.
Saxenda is a prescription-only injectable treatment that requires clinical assessment to determine suitability, particularly regarding contraindications like personal history of medullary thyroid carcinoma or pregnancy. Whilst Cured Pharmacy specialises in orlistat-based weight loss treatments, our clinical team can discuss whether injectable GLP-1 medications align with your weight management goals during your free consultation.
We offer next day delivery across the UK with 100% discreet packaging. Orders placed before our daily cut-off time arrive within 24 hours, ensuring you can start treatment promptly following prescriber approval. Our transparent pricing model shows costs upfront before consultation — no hidden fees or surprise charges. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services, ensuring every prescription meets MHRA and GPhC standards.
Scientific References
- Sjöström, L., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
- Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Xenical and Saxenda are prescription-only medicines that must be used under medical supervision alongside a reduced-calorie diet and increased physical activity.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.


